AVMA news
From Congress to the courtroom, AVMA advocates for veterinarians
The AVMA’s advocacy on behalf of its members covers practically every aspect of veterinary medicine and takes place in the federal government,…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
Animal health advocacy
The AVMA’s advocacy work provides critical support for the work veterinary teams do every day to protect, promote, and advance animal health. Learn…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
AVMA news
AVMA CEO addresses workforce trends
Speaking to animal health industry leaders this August, AVMA CEO Dr. Janet Donlin talked about the challenges and opportunities facing the veterinary…
AVMA news
VCPR requirements fuel state legislative activity
The issue of whether to establish a veterinarian-client-patient-relationship (VCPR) through an in-person examination or solely electronic means has…
AVMA news
Bill seeks extension for new small business reporting requirement
As of January 1, small U.S. businesses are required to report ownership details to the U.S. Department of Treasury. However, legislators are seeking…